Document is current
Any future updates will be listed below
-
Authors
Payet, Rocky D https://orcid.org/0000-0002-6990-8418
Aouidate, Adnane
Casson, Rebecca
Houghton, Alan
Pham, Mai-Truc https://orcid.org/0000-0003-4819-2278
Osbourn, Anne https://orcid.org/0000-0003-2195-5810
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (Novozymes Prize 2023)
Wellcome Trust (#227375/Z/23/Z)
UKRI | Biotechnology and Biological Sciences Research Council (APP3941)
UKRI | Biotechnology and Biological Sciences Research Council (BB/X01097X/1)
John Innes Foundation
- License Information
-
More Information
Article History
Received: 21 February 2025
Revised: 19 May 2025
Accepted: 2 June 2025
First Online: 3 July 2025
Disclosure and competing interests statement
: AO is a co-founder and CSO of HotHouse Therapeutics. The other authors declare no competing interests.
